Treatment of advanced Hodgkin lymphoma has evolved dramatically in the last 10 years, especially with the introduction of PET-response adapted treatment and the introduction of novel agents. Martin Hutchings, MD, PhD from the Copenhagen University Hospital, Copenhagen, Denmark discusses the latest advances and how they have changed the way we treat advanced Hodgkin lymphoma. This video was recorded at the EBMT 2018 Annual Meeting, held in Lisbon, Portugal.
EBMT 2018: Updates on advanced Hodgkin lymphoma treatment
